Bax:Bcl2 Cancer Research Results
Bax:Bcl2, Bax:Bcl2 ratio: Click to Expand ⟱
| Source: |
| Type: |
Bax and Bcl-2 are the major members of Bcl-2 family that play a key role in tumor progression or inhibition of intrinsic apoptotic pathway triggered by mitochondrial dysfunction.
Bax/Bcl-2 ratio is typically significantly lower in tumors.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
- |
in-vivo, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
T47D |
|
|
|
- |
in-vitro, |
BC, |
BT549 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-361 |
|
|
|
TumCP↓, COX2↓, *angioG↓, Cyt‑c↑, CREB2↓, cFos↓, NF-kB↓, HATs↓, cl‑Casp3↑, cl‑Casp9↑, Bax:Bcl2↑, Apoptosis↑, *toxicity↓,
Inflam↓, IL6↓, MCP1↓, COX2↓, PGE2↓, MMP2↓, MMP9↓, DNAdam↑, eff↝, Telomerase↓, Bcl-2↓, AMPK↑, ROS↑, MMP↓, ATP↓, p‑mTORC1↓, p‑S6K↓, ERK↓, PI3K↓, PTEN↑, Akt↓, Raf↓, MEK↓, Dose↓, Dose↑, selectivity↑, TumCCA↑, eff↑, EGFR↓, Glycolysis↓, Dose?, p27↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Casp3↑, Casp9↑, VEGFR2↓, ChemoSen↑, eff↑, eff↑, PGE2↓, JAK2↓, STAT3↓, CXCR4↓, CCR7↓, uPA↓, CSCs↓, EMT↓, Diff↓, CD133↓, Nestin↓, n-MYC↓, NOTCH↓, SOX2↓, Hif1a↓, VEGF↓, RadioS↑,
*tumCV↓, *ROS↑, *MMP↓, *Fas↑, *P53↑, *P21↑, *Bax:Bcl2↑, *Casp3↑, *Casp8↑, *Casp9↑, *cl‑PARP↑, *TumCCA↑, *P21↑, *cycE/CCNE↑, *cycA1/CCNA1↓, *CDK2↓,
*TumCCA↑, *ROS↑, *MMP↓, *Fas↑, *P53↑, *P21↓, *Bax:Bcl2↑, *cl‑Casp3↑, *cl‑Casp8↑, *cl‑Casp9↑, *cl‑PARP↑,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, MEK↓, 1, MMP↓, 1, Raf↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, Glycolysis↓, 1, p‑S6K↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 1, Bax:Bcl2↑, 2, Bcl-2↓, 1, Casp3↑, 1, cl‑Casp3↑, 1, Casp9↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 1, p27↑, 1, Telomerase↓, 1,
Transcription & Epigenetics ⓘ
HATs↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 1, cycE/CCNE↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
CD133↓, 1, cFos↓, 1, CREB2↓, 1, CSCs↓, 1, Diff↓, 1, EMT↓, 1, ERK↓, 1, p‑mTORC1↓, 1, n-MYC↓, 1, Nestin↓, 1, NOTCH↓, 1, PI3K↓, 1, PTEN↑, 1, SOX2↓, 1, STAT3↓, 1,
Migration ⓘ
MMP2↓, 1, MMP9↓, 1, TumCP↓, 1, uPA↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, Hif1a↓, 1, VEGF↓, 1, VEGFR2↓, 1,
Immune & Inflammatory Signaling ⓘ
CCR7↓, 1, COX2↓, 2, CXCR4↓, 1, IL6↓, 1, Inflam↓, 1, JAK2↓, 1, MCP1↓, 1, NF-kB↓, 1, PGE2↓, 2,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, Dose?, 1, Dose↓, 1, Dose↑, 1, eff↑, 3, eff↝, 1, RadioS↑, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
EGFR↓, 1, IL6↓, 1,
Total Targets: 68
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 2,
Mitochondria & Bioenergetics ⓘ
MMP↓, 2,
Cell Death ⓘ
Bax:Bcl2↑, 2, Casp3↑, 1, cl‑Casp3↑, 1, Casp8↑, 1, cl‑Casp8↑, 1, Casp9↑, 1, cl‑Casp9↑, 1, Fas↑, 2,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
DNA Damage & Repair ⓘ
P53↑, 2, cl‑PARP↑, 2,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, cycA1/CCNA1↓, 1, cycE/CCNE↑, 1, P21↓, 1, P21↑, 2, TumCCA↑, 2,
Angiogenesis & Vasculature ⓘ
angioG↓, 1,
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 21
Scientific Paper Hit Count for: Bax:Bcl2, Bax:Bcl2 ratio
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:352 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page